By studying large series of unselected breast carcinomas by genome-wide sequencing, Davies et al. [25] found that mutational signatures 6, 20, and 26 recognized MMR deficiency more faithfully than sequencing of MMR genes for mutations or analyzing exome data for MSI. Here, MRC1 is linked to breast carcinoma.